TFX Working Capital Per Revenue	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter	(Mar 30 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 29 2024) III. Quarter
Y / Y Working Capital Change	37.75 %	14.34 %	0.05 %	2.64 %	-41.76 %
Y / Y Revenue Change	19.43 %	4.09 %	-4.98 %	2.85 %	2.39 %
Working Capital Per Revenue	0.31	0.29	0.29	0.28	0.28
Working Capital Per Revenue Ranking	# 833	# 1703	# 1765	# 1390	# 414
Seq. Working Capital Change	20.37 %	16.77 %	5.02 %	-6.68 %	-0.09 %
Seq. Revenue Change	16.99 %	11.37 %	-12 %	4.15 %	1.96 %

New: More TFX's historic Working Capital Per Revenue Ratios >>

Financial strength information for the Healthcare sector >> Back to TFX Financial Strength Comparisons >> See TFX Balance Sheets

Comment on TFX's Working Capital Per Revenue in the third quarter 2025

Teleflex Incorporated's Working Capital Per Revenue sequentially grew to 0.31 during the Q3 2025, below the Teleflex Incorporated average.

Within Healthcare sector 11 other companies have achieved lower Working Capital Per Revenue during the Q3 2025. While Teleflex Incorporated Working Capital Per Revenue overall ranking has impoved so far in the Q3 2025 to 833, from total ranking in the second quarter 2025 at 1703.

Working Capital Per Revenue Ranking
Within:	No.
Industry	# 4
Sector	# 12
S&P 500	# 833

Working Capital Per Revenue Statistics
High	Average	Low
0.51	0.32	0.22
(Oct 01 2017)		(Dec. 30, 2015)

Financial Statements
Teleflex Incorporated's Working Capital	$ 1,213 Millions	Visit TFX's Balance sheet
Teleflex Incorporated's Revenues	$ 913 Millions	Visit TFX's Income Statement
Where are TFX's Sales coming from?		Visit TFX's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 28 2025, within Healthcare Sector	Working Capital Per Revenue
Alpha Pro Tech Ltd	0.83
Biomerica Inc	0.82
Sarepta Therapeutics Inc	0.80
Reshape Lifesciences Inc	0.80
Neuropace Inc	0.79
Glaukos Corp	0.79
10x Genomics Inc	0.78
Fortress Biotech Inc	0.78
Scientific Industries Inc	0.77
Guardant Health Inc	0.77
Irhythm Technologies Inc	0.76
Hologic Inc	0.73
Invivyd Inc	0.72
Veracyte Inc	0.72
Emergent Biosolutions Inc	0.72
Alkermes Plc	0.72
Adaptive Biotechnologies Corporation	0.71
Halozyme Therapeutics Inc	0.71
Alnylam Pharmaceuticals Inc	0.70
Lakeland Industries Inc	0.69
Opko Health Inc	0.69
Twist Bioscience Corporation	0.69
Mirum Pharmaceuticals Inc	0.69
Mallinckrodt Plc	0.67
Ardelyx inc	0.67
Anika Therapeutics Inc	0.67
Penumbra Inc	0.66
Caredx Inc	0.66
Intuitive Surgical Inc	0.66
Tela Bio Inc	0.66

Date modified: 2025-11-06T22:41:15+00:00

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.